ロード中...
AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models
Huntington disease (HD) is a fatal neurodegenerative disorder caused by an autosomal dominant CAG repeat expansion in the huntingtin (HTT) gene. The translated expanded polyglutamine repeat in the HTT protein is known to cause toxic gain of function. We showed previously that strong HTT lowering pre...
保存先:
| 出版年: | Mol Ther Methods Clin Dev |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Gene & Cell Therapy
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6446047/ https://ncbi.nlm.nih.gov/pubmed/30984798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2019.03.002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|